COVID 19: DCGI approves Serum, Bharat Biotech vaccines for emergency use.

0
195

The Drugs Controller General of India (DCGI) on Sunday approved the Oxford coronavirus vaccine and Bharat Biotech’s Covaxin, making it India’s first vaccines against the pandemic, for restricted emergency use.
Addressing media in Delhi, the Drugs Controller General of India, VG Somani, said, “The… vaccines of Serum Institute (AstraZeneca/Oxford vaccine) and Bharat Biotech are being approved for restricted use in emergency situations.”
Prime Minister Narendra Modi termed the approval a decisive turning to strengthen India’s fight against coronavirus.
Prime Minister Narendra Modi tweeted, “A decisive turning point to strengthen a spirited fight! DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators.”
He also saluted the frontline workers who have been leading the country”s fight against the virus, even as the Prime Minister says this shows the eagerness of our scientific community to fulfill the dream of an Aatmanirbhar Bharat.
“It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfill the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion,” Prime Minister Tweeted.